Streetbeat News

Regulatory

SPY

VGK

The U.S. government is planning to impose sanctions on around 150 companies and individuals accused of aiding Russia, according to the Wall Street Journal. The impact on ETFs like SPY and VGK is yet to be determined.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 1:18 pm

BUD

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) is expanding its beer business nationally, starting in Georgia. The expansion follows the acquisition of eight beer and beverage brands from Anheuser-Busch (NYSE: BUD), making Tilray the 5th largest craft beer business in the U.S. Tilray's CEO anticipates creating a beer infused with cannabis upon legalization in the U.S.

Portfolio Pulse from Jelena Martinovic

September 14, 2023 | 1:16 pm

CRM

MSFT

Microsoft Corp's (NASDAQ:MSFT) attempt to address EU concerns about its Teams video-conferencing app has failed, leading to the preparation of a formal complaint by the European Union's antitrust enforcers. The EU's investigation was prompted by a complaint from Salesforce Inc's (NYSE:CRM) Slack platform. Despite Microsoft's proposal to separate Teams from its broader business software package, regulators' worries persist. Microsoft may face further challenges in the European market.

Portfolio Pulse from Anusuya Lahiri

September 14, 2023 | 1:14 pm

UUP

The U.S. economy is facing renewed inflation concerns as the Producer Price Index (PPI) recorded a year-on-year increase of 1.6% in August 2023, exceeding economists' consensus estimate of 1.2%. The Consumer Price Index (CPI) for August also surged to 3.7% year-on-year. The U.S. dollar index (DXY), monitored through the Invesco DB USD Index Bullish Fund ETF (NYSE:UUP), gained 0.4% in response. These inflation figures could influence the Federal Reserve's decision on interest rates in their upcoming meeting.

Portfolio Pulse from Piero Cingari

September 14, 2023 | 1:05 pm

AAPL

BTCUSD

TSLA

The White House accuses China of banning iPhones as retaliation in the ongoing trade war. Cathie Wood sells $13.88M worth of Tesla stock following a 9% rally. Shiba Inu token burn surpasses 61M as whales multiply net-flow by over 275% in 7 days. Singapore is set to review ride-hailing regulations, with Grab and GoTo on the radar. Tesla CEO Elon Musk suggests a solution for keying in Cybertruck. Ford's Jim Farley fires back at UAW leader as strike deadline approaches.

Portfolio Pulse from Akanksha Bakshi

September 14, 2023 | 1:02 pm

VGK

European Central Bank's President, Christine Lagarde, has indicated that economic growth is expected to be subdued, with recent indicators suggesting a weak Q3. This could potentially impact the performance of the Vanguard FTSE Europe ETF (VGK), which tracks the performance of the European stock market.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:55 pm

CYTO

Altamira Therapeutics has reported additional efficacy outcomes from its Bentrio clinical trial in seasonal allergic rhinitis. The NASAR clinical trial demonstrated the efficacy and tolerability of Bentrio nasal spray in treating seasonal allergic rhinitis, meeting both primary and secondary efficacy endpoints. The treatment also showed a statistically significant improvement in health-related quality of life secondary efficacy endpoint. The efficacy was demonstrated from the first day of the 2-week treatment period and across allergy symptoms and functional problems. Bentrio treatment was associated with a reduced need for relief medication.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:49 pm

BNBUSD

COIN

ETHUSD

XRPUSD

Ethereum co-founder, Joseph Lubin, expressed confidence that disagreements between crypto companies and the SEC will be resolved favorably. He drew parallels with past technological advancements and emphasized that decentralized protocols, blockchain, and cryptocurrency align with U.S. philosophies. Major crypto entities, including Binance, Coinbase, and Ripple, are currently in legal battles with the SEC over alleged regulatory breaches.

Portfolio Pulse from Murtuza Merchant

September 14, 2023 | 12:47 pm

HEPA

Hepion Pharmaceuticals' drug, Rencofilstat, has shown positive outcomes in a translational study on Idiopathic Pulmonary Fibrosis (IPF). Proteomics analysis revealed that Rencofilstat improved aberrant protein profiles in IPF tissues. The drug showed superior effects alone and in combination with pirfenidone and nintedanib.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:47 pm

SPY

The USA Core Producer Price Index (PPI) for August was reported at 0.2%, in line with estimates but lower than the 0.4% reported in the previous month.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 12:42 pm